You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 241 No. 22, June 1, 1979 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Heparin-induced spinal fractures

J. W. Squires and L. W. Pinch

A 27-year-old woman received heparin sodium for 152 days because of antepartum iliofemoral thrombophlebitis. At the end of this time, spinal osteoporosis and multiple vertebral fractures became clinically evident and were attributed to the prolonged administration of heparin. Previously reported cases of "heparin osteoporosis" were reviewed. The significance of the daily dose of heparin and the duration of therapy are reemphasized. This therapeutic complication and the management of antepartum iliofemoral thrombophlebitis are discussed. Prolonged administration of heparin in daily doses exceeding 10,000 units is potentially hazardous.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cbfa-1 (runx-2) and osteocalcin expression by human osteoblasts in heparin osteoporosis in vitro.
Handschin et al.
CLIN APPL THROMB HEMOST 2006;12:465-472.
ABSTRACT  

Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control
Carlin et al.
Hum Reprod 2004;19:1211-1214.
ABSTRACT | FULL TEXT  

Heparin acts synergistically with interleukin-11 to induce STAT3 activation and in vitro osteoclast formation
Walton et al.
Blood 2002;100:2530-2536.
ABSTRACT | FULL TEXT  

Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
Hirsh et al.
Chest 2001;119:64S-94S.
FULL TEXT  

Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers et al.
Chest 2001;119:176S-193S.
FULL TEXT  

Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study
Backos et al.
Hum Reprod 1999;14:2876-2880.
ABSTRACT | FULL TEXT  

Management of Deep Vein Thrombosis and Pulmonary Embolism : A Statement for Healthcare Professionals From the Council on Thrombosis (in Consultation With the Council on Cardiovascular Radiology), American Heart Association
Hirsh and Hoak
Circulation 1996;93:2212-2245.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.